New Drug Is Effective In Reducing Rejection In Heart Transplant

Armen Hareyan's picture
Advertisement

Heart Transplant

A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.

Oregon Health

Advertisement